CagriSema 2.4mg

CagriSema 2.4mg Chemische Eigenschaften,Einsatz,Produktion Methoden

Definition

CagriSema is a fixed-dose combination therapy of 2.4mg semaglutide with 2.4mg cagrilintide, in obesity patients. Cagrilintide is a long-acting amylin analogue potentiating semaglutide’s weight loss effects.

CagriSema 2.4mg Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CagriSema 2.4mg Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Anko Intermational Trade Limited	+86-18073326374	sales@goodpeptides.com	China	59	58

---

• CagriSema 2.4mg